This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Martin Gieseler: Innovator in Pharmaceutical Treatments
Introduction
Martin Gieseler is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of withdrawal symptoms associated with drug abuse. His innovative approach has led to the development of new therapeutic agents that aim to improve patient outcomes.
Latest Patents
Gieseler holds a patent for a pharmaceutical agent designed for the treatment of withdrawal symptoms. This patent describes the use of non-NMDA receptor antagonists, such as quisqualate or kainate antagonists, along with their physiologically compatible salts. The patent also explores the combination of these new pharmaceutical agents with NMDA antagonists, showcasing a novel approach to addressing the challenges of drug withdrawal. He has 1 patent to his name.
Career Highlights
Martin Gieseler is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Schering has allowed him to focus on innovative solutions that address critical health issues. Gieseler's research and development efforts have positioned him as a key figure in the advancement of pharmaceutical treatments.
Collaborations
Throughout his career, Gieseler has collaborated with esteemed colleagues, including Karin G. Steppuhn and Karin Bressler. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.
Conclusion
Martin Gieseler's contributions to the pharmaceutical field, particularly in the treatment of withdrawal symptoms, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of new therapeutic agents that can make a difference in the lives of individuals facing drug addiction.